Despite its rapid, and in the case of CHF, sustained release into general circulation, H-FABP not only acted as an indicator of cellular damage, but also a marker of myocytal dyshomeostasis, and thus, functional impairment of the myocardium. The gene discussed is FABP3; the disease is congestive heart failure.